On-X Aortic Heart Valve with Anatomic Sewing Ring and Extended Holder ONXANE-19Recalls & reported problems
On-X Life Technologies, Inc. · The On-X® Prosthetic Heart Valve is a bileaflet mechanical heart valve, which consists of an orifice housing and two leaflets. The orifice inflow area has a flared inlet designed to reduce flow turbulence, and the outflow rim consists of leaflet guards designed to protect the leaflets while in the closed position. The leaflets rotate around tabs located within the inner circumference of the orifice ring. In the closed position, each leaflet forms a nominal angle of 40º relative to the plane of the orifice. In the open position, the plane of each leaflet forms a nominal angle of 90deg relative to the plane of the orifice. The leaflets have a travel arc of 50deg to the closed position. The orifice, or housing, is composed of a graphite substrate coated with On-X® Carbon, a pure unalloyed form of pyrolytic carbon. The leaflets consist of On-X® Carbon deposited on a graphite substrate, which is impregnated with 10 weight% tungsten to provide radiopacity. The sewing cuff is constructed of polytetrafluoroethylene (PTFE) fabric mounted on the orifice using titanium retaining rings and 5-0 suture material. This form of sewing cuff attachment to the orifice allows for rotation of the sewing cuff in situ during implantation. Orientation reference marks are provided on the sewing cuff for valve orientation. The On-X® Prosthetic Heart Valve is available in 3 aortic and 2 mitral sewing cuff configurations. Aortic configurations are available in sizes 19, 21, 23, 25, and 27/29 mm. The standard mitral cuff is available in sizes 23, 25, 27/29 and 31/33, while the Conform-X® mitral cuff is available in size 25/33 only. Further detail for the On-X prosthetic heart valve is described in the Summary of Safety and Effectiveness documents for the On-X heart valves: http://www.accessdata.fda.gov/cdrh_docs/pdf/P000037b.pdf (aortic), and http://www.accessdata.fda.gov/cdrh_docs/pdf/P000037S001b.pdf (mitral). · Class 3 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 6
- Deaths reported
- 0
- Injuries reported
- 6
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00851788001648), received between Sep 21, 2016 and Nov 1, 2024 — classified as 6 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (2 reports).
4 other recalls cover devices cleared under the same FDA submission (P000037); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem6
- Insufficient Device Problem Information2
Patient problems
- Insufficient Information2
- Aortic Insufficiency1
- Aortic Valve Stenosis1
- Balance Problems1
- Cardiovascular Dysfunction/Insufficiency1
- Dyspnea1
- Fatigue1
- No Information1
Recent adverse event reports
The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.
InjuryNov 1, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ACCORDING TO THE INITIAL REPORT, AN IMPLANT REGISTRATION CARD (IRC) WAS RECEIVED FOR A PATIENT WITH AN EXISTING AORTIC IMPLANT. THE REASON FOR EXPLANT IS CURRENTLY UNKNOWN. THIS VALVE WAS IMPLANTED ON (B)(6) 2018 AND EXPLANTED ON (B)(6) 2024.
Patient problems: Cardiovascular Dysfunction/Insufficiency; Insufficient Information
MAUDE report 20588812 ↗InjuryMay 11, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ACCORDING TO THE INITIAL REPORT SUBMITTED BY AN ON-X PATIENT, "I HAD AORTIC VALVE REPLACEMENT AND MITRAL VALVE REPLACEMENT IN FEBRUARY 2022. SZMM 25 SN: (B)(6); SZMM19, SN (B)(6). ACCORDING TO ECHO VALVES ARE NOT WORKING, I STILL HAVE AORTIC STENOSIS AND MITRAL VALVE REGURGITATION, AND NOW TRICUSPID VALVE HAS REGURGITATION. I HAVE SHORTNESS OF BREATH, LOSS OF BALANCE, FATIGUE, AND FEEL WORSE THAN BEFORE SURGERY. I AM NOT HAPPY WITH CURRENT CARDIOLOGIST AND MY SURGEON HAS LEFT AREA." THIS REPORT WILL BE RELEGATED TO ONXANE-19, SN (B)(6). THIS INVESTIGATION IS CURRENTLY ONGOING. ANY ADDITIONAL INFORMATION WILL BE PROVIDED IN THE FOLLOW-UP REPORT. THIS REPORT IS BEING SUBMITTED AS REQUIRED BY FEDERAL REGULATIONS AND DOES NOT CONSTITUTE AN ADMISSION THAT THE DEVICE CAUSED OR CONTRIBUTED TO THE REPORTED EVENT. FURTHERMORE, THIS REPORT REFLECTS THE EVENT AS ALLEGED BY THE COMPLAINANT AND DOES NOT IMPLY THAT THE INFORMATION REPORTED TO ARTIVION IS ACCURATE OR HAS BEEN CONFIRMED BY ARTIVION.
Patient problems: Aortic Valve Stenosis; Balance Problems; Dyspnea; Fatigue; Tricuspid Valve Insufficiency/ Regurgitation
MAUDE report 16911334 ↗InjuryFeb 15, 2023Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
AN IMPLANT REGISTRATION CARD FOR ONXANE-23 SN (B)(4), IMPLANTED (B)(6) 2022, WAS RETURNED FROM THE USER FACILITY FOR A PATIENT WITH AN EXISTING ON-X HEART VALVE (ONXANE-19 SN (B)(4) IMPLANTED (B)(6) 2014. BOTH IRCS NOTATE THE VALVES WERE IMPLANTED IN THE AORTIC POSITION SUGGESTING THE ONXANE-19 SN (B)(4) WAS EXPLANTED. THIS INVESTIGATION IS RELEGATED TO ONXANE-19 SN (B)(4).
Patient problems: Insufficient Information; Valvular Stenosis
MAUDE report 16378991 ↗InjuryMay 14, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ACCORDING TO THE REPORT RECEIVED VIA EMAIL ON 16-JUN-2021, "PATIENT IS SUBJECT # 370 IN THE ON-X POST APPROVAL STUDY. PATIENT WAS HOSPITALIZED FOR A PACEMAKER RELATED REASON. NO OTHER DETAILS ARE AVAILABLE AT THIS POINT." PER THE ADJUDICATION FORM DURING THIS HOSPITALIZATION THE PATIENT HAD A PACEMAKER IMPLANTED. THIS IS NOT RELATED TO THE IMPLANTED ON-X VALVE. ADDITIONAL INFORMATION RECEIVED RELAYED THE PATIENT WAS ADMITTED ON (B)(6) 2019 FOR ELECTIVE LEFT KNEE REPLACEMENT. ON (B)(6) 2019 THE PATIENT AWOKE WITH BILATERAL BLURRY VISION, AND IS BEING EVALUATED FOR STROKE. (B)(6) 2019: CT OF HEAD - OCCIPITAL LOBES WITH BILATERAL HYPODENSITY. RIGHT PARIETAL LOBE HYPODENSITY. SUGGESTIVE OF EVOLVING INFARCTS VS PRES. ASSESSMENT: SUSPECTED ACUTE INFARCTS INVOLVING THE OCCIPITAL + PARIETAL LOBES RELATED TO BEING OFF OF ANTICOAGULATION + MECHANICAL VALVE.
Patient problems: Stroke/CVA
MAUDE report 14403660 ↗InjuryApr 30, 2020Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
ACCORDING TO THE INITIAL REPORT, ONXANE-19, SERIAL NUMBER (B)(4) WAS IMPLANTED AND EXPLANTED WITHIN THE SAME PROCEDURE.
Patient problems: No Information
MAUDE report 10013846 ↗InjurySep 21, 2016Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE PATIENT RECEIVED THE ON-X AORTIC HEART VALVE WITH ANATOMIC SEWING RING AND EXTENDER HOLDER - 19MM IN (B)(6) 2016 DUE TO SEVERE AI (ASYMPTOMATIC). SHE RETURNED FOR HIP REPLACEMENT WORK WHEN A NEW MURMUR AND AN X-RAY SHOWED SOME PNEUMOPERITONEUM. ECHO SHOWED SEVER AI (VALVE DEHISCENCE) AND LIKELY A VENTRICULAR SEPTAL DEFECT (V. SINUS OF VALSALVA ANEURYSM WITH RUPTURE INTO THE RV) WITH EF 55%, DEPRESSED LV FUNCTION, DEPRESSED RV FUNCTION. THERE WAS NO EVIDENCE OF INFECTION. A SECONDARY STERNOTOMY, REMOVAL OF THE PREVIOUSLY PLACED ON-X AORTIC VALVE, REPAIR (PATCH) SUBAORTIC VENTRICULAR SEPTAL DEFECT, AND REPAIR (PATCH) AORTIC PSEUDOANEURYSM AT THE LEVEL OF THE AORTICOMITRAL CONFLUENCE WAS PERFORMED. AN ON-X AORTIC HEART VALVE WITH ANATOMIC SEWING RING - 21MM WAS IMPLANTED.
Patient problems: Aortic Insufficiency; Pseudoaneurysm
MAUDE report 5967522 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P000037. One submission often covers many models, so check the product and lot details in each record.
- Z-2133-2026 · Feb 1, 2026 · Open, ClassifiedOn-X Mitral Heart Valve with Conform-X Sewing Ring, Model: ONXMC-25/33
- Z-1073-2019 · Jan 17, 2019 · TerminatedOn-X Aortic Heart Valve with Anatomic Sewing Ring Product Usage: The On-X Prosthetic Heart Valve is indicated for the replacement of diseased, damaged, or malfunctioning native
- Z-2715-2017 · Jun 12, 2015 · TerminatedOn-X Prosthetic Heart Valve Product Usage: Indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic heart valves in the aortic and mitral positio
- Z-3108-2017 · Feb 12, 2014 · TerminatedOn-X Prosthetic Heart Valve with Gelweave Valsalva Graft, single use. Indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic heart valves in th
Other Heart-Valve, Mechanical devices
- On-X Mitral Heart Valve with Conform-X Sewing Ring ONXMC-25/33On-X Life Technologies, Inc. · Heart-Valve, Mechanical1 recall1 death34 reports
- SJM Regent™ AGFN-756St. Jude Medical, Inc. · HEART-VALVE, MECHANICAL3 deaths70 reports
- SJM Regent™ AGFN-756St. Jude Medical, Inc. · HEART-VALVE, MECHANICAL5 deaths66 reports
- SJM Regent™ 23AGFN-756St. Jude Medical, Inc. · HEART-VALVE, MECHANICAL3 deaths44 reports
- CARBOMEDICS SUPRA-ANNULAR (TOP HAT) S5-021Corcym Srl · HEART-VALVE, MECHANICAL7 deaths37 reports
- Regent™ 21AGFN-756St. Jude Medical, Inc. · HEART-VALVE, MECHANICAL3 deaths35 reports
- Regent™ 23AGFN-756St. Jude Medical, Inc. · HEART-VALVE, MECHANICAL2 deaths33 reports
- Regent™ 19AGFN-756St. Jude Medical, Inc. · HEART-VALVE, MECHANICAL31 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page